Managing global release in a changing regulatory environment

An analytical testing perspective Whether you are using an insourcing or outsourcing strategy and working with a CMO or CRO, biotechs and pharmaceutical companies are all pointing toward the same goal: rapidly achieving commercialization of their therapy. However, there are multiple approaches in early phase development that can greatly affect …

Biomarkers & Diagnostics: Growing Influence on Drug Development for NAFLD/NASH

Biomarkers and diagnostics are playing an ever-increasing role in drug development. Personalized medicines, defined as drug therapies used alongside specific diagnostic tests, topped 40% of all FDA approvals in 2018. Across biopharma, drug developers increased their utilization of selection biomarkers, significantly improving the probability of success for their clinical programs.1, …

covid-19 covance labcorp diagnostics drug development

Covance and LabCorp Deliver Unmatched COVID-19 Diagnostic and Therapeutic Applications

We’re in this together: How Covance and LabCorp are delivering unmatched acceleration of COVID-19 diagnostic and therapeutic applications Accelerating much needed COVID-19 testing, vaccines and treatment options across the world can’t be done alone. We’re in this together and ready to apply our unique combination of solutions that blend Covance …

Covance Becomes First Major Central Laboratory in Japan to Add Anatomic Pathology and Histology Services

In an effort to help clients get faster clinical trial results and support development of today’s novel therapies, Covance recently expanded its Asia-Pacific footprint by becoming the first major central laboratory in Japan to add anatomic pathology and histology (APH) services at its Kawagoe facility. Learn more about how this …

Navigating COVID-19: The Importance of a Nimble Reimbursement Call Center Operation

The impact of COVID-19 on reimbursement call center operations has the potential to be significant. However, a proactive crisis management plan and a dispersed, redundant operating model can go a long way towards safeguarding your patient support programs. As governments and citizens address challenges posed by this global pandemic, many …

Addressing the Challenges of Data Management for Pharmaceutical and Biotechnology Companies: Introducing Laboratory FSPx

Data currency management of clinical trial laboratory results can be a point of frustration for today’s pharmaceutical and biotechnology companies. Whether the data is coming from a contract research organization (CRO), a central laboratory or third-party laboratories, the need for timely availability of clean data based on unique sponsor format/industry …